These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22430841)
1. [The genetic profile of multiple sclerosis: risk genes and the "dark matter"]. Lill CM; Zipp F Nervenarzt; 2012 Jun; 83(6):705-13. PubMed ID: 22430841 [TBL] [Abstract][Full Text] [Related]
2. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Gourraud PA; McElroy JP; Caillier SJ; Johnson BA; Santaniello A; Hauser SL; Oksenberg JR Ann Neurol; 2011 Jan; 69(1):65-74. PubMed ID: 21280076 [TBL] [Abstract][Full Text] [Related]
3. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility. Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869 [TBL] [Abstract][Full Text] [Related]
4. Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Nischwitz S; Cepok S; Kroner A; Wolf C; Knop M; Müller-Sarnowski F; Pfister H; Roeske D; Rieckmann P; Hemmer B; Ising M; Uhr M; Bettecken T; Holsboer F; Müller-Myhsok B; Weber F J Neuroimmunol; 2010 Oct; 227(1-2):162-6. PubMed ID: 20598377 [TBL] [Abstract][Full Text] [Related]
6. Revealing the genetic basis of multiple sclerosis: are we there yet? Baranzini SE Curr Opin Genet Dev; 2011 Jun; 21(3):317-24. PubMed ID: 21247752 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Jakkula E; Leppä V; Sulonen AM; Varilo T; Kallio S; Kemppinen A; Purcell S; Koivisto K; Tienari P; Sumelahti ML; Elovaara I; Pirttilä T; Reunanen M; Aromaa A; Oturai AB; Søndergaard HB; Harbo HF; Mero IL; Gabriel SB; Mirel DB; Hauser SL; Kappos L; Polman C; De Jager PL; Hafler DA; Daly MJ; Palotie A; Saarela J; Peltonen L Am J Hum Genet; 2010 Feb; 86(2):285-91. PubMed ID: 20159113 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis: the impact of genome-wide association studies identified disease risk loci. Kulakova O; Bashinskaya V; Kiselev I; Baulina N; Tsareva E; Nikolaev R; Kozin M; Shchur S; Favorov A; Boyko A; Favorova O Pharmacogenomics; 2017 Nov; 18(17):1563-1574. PubMed ID: 29095108 [TBL] [Abstract][Full Text] [Related]
15. Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models. Burnard SM; Lea RA; Benton M; Eccles D; Kennedy DW; Lechner-Scott J; Scott RJ Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052430 [TBL] [Abstract][Full Text] [Related]
16. A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. Bashinskaya VV; Kulakova OG; Boyko AN; Favorov AV; Favorova OO Hum Genet; 2015 Nov; 134(11-12):1143-62. PubMed ID: 26407970 [TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis genetics. Canto E; Oksenberg JR Mult Scler; 2018 Jan; 24(1):75-79. PubMed ID: 29307290 [TBL] [Abstract][Full Text] [Related]
18. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Handel AE; Handunnetthi L; Giovannoni G; Ebers GC; Ramagopalan SV Eur J Neurol; 2010 Sep; 17(9):1210-1214. PubMed ID: 20345929 [TBL] [Abstract][Full Text] [Related]
19. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews. Khankhanian P; Matsushita T; Madireddy L; Lizée A; Din L; Moré JM; Gourraud PA; Hauser SL; Baranzini SE; Oksenberg JR BMC Med Genet; 2015 Jul; 16():55. PubMed ID: 26212423 [TBL] [Abstract][Full Text] [Related]